AI Verdict
IDXX has stronger fundamentals based on our AI analysis.
ABBV vs IDXX Fundamental Comparison
| Metric | ABBV | IDXX |
|---|---|---|
| Revenue | $61.2B | $4.3B |
| Net Income | $4.2B | $1.1B |
| Net Margin | 6.9% | 24.6% |
| ROE | N/A | 66.0% |
| ROA | 3.2% | 31.6% |
| Current Ratio | 0.67x | 1.23x |
| Debt/Equity | N/A | 0.28x |
| EPS | $2.36 | $13.08 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs IDXX: Frequently Asked Questions
Is ABBV or IDXX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IDXX has stronger fundamentals. ABBV is rated HOLD (70% confidence) while IDXX is rated STRONG BUY (87% confidence). This is not investment advice.
How does ABBV compare to IDXX fundamentally?
AbbVie Inc. has ROE of N/A vs IDEXX LABORATORIES INC /DE's 66.0%. Net margins are 6.9% vs 24.6% respectively.
Which stock pays higher dividends, ABBV or IDXX?
ABBV has a dividend yield of N/A or no dividend while IDXX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or IDXX for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while IDXX has STRONG BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs IDXX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs IDXX, the AI consensus favors IDXX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.